The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 12, 2025

Filed:

Sep. 10, 2018
Applicant:

Poseida Therapeutics, Inc., San Diego, CA (US);

Inventors:

Eric M. Ostertag, San Diego, CA (US);

Devon Shedlock, San Diego, CA (US);

Assignee:

Poseida Therapeutics, Inc., San Diego, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/85 (2006.01); A61K 40/11 (2025.01); A61K 40/31 (2025.01); A61K 40/40 (2025.01); A61K 40/42 (2025.01); A61P 7/04 (2006.01); C07K 14/725 (2006.01); C07K 16/28 (2006.01); C12N 9/06 (2006.01); C12N 9/64 (2006.01);
U.S. Cl.
CPC ...
C12N 15/85 (2013.01); A61K 40/11 (2025.01); A61K 40/31 (2025.01); A61K 40/40 (2025.01); A61K 40/4215 (2025.01); A61P 7/04 (2018.01); C07K 14/7051 (2013.01); C07K 16/2878 (2013.01); C12N 9/003 (2013.01); C12N 9/644 (2013.01); C12Y 105/01003 (2013.01); C12Y 304/21022 (2013.01); C07K 2319/02 (2013.01); C07K 2319/03 (2013.01); C12N 2830/002 (2013.01);
Abstract

Disclosed are composition comprising (a) an inducible transgene construct, comprising a sequence encoding an inducible promoter and a sequence encoding a transgene, and (b) a receptor construct, comprising a sequence encoding a constitutive promoter and a sequence encoding an exogenous receptor, wherein, upon integration of the construct of (a) and the construct of (b) into a genomic sequence of a cell, the exogenous reporter is expressed, and wherein the exogenous reporter, upon binding a ligand, transduces an intracellular signal that targets the inducible promoter of (a) to modify gene expression. Methods for introducing compositions into cells and the use of the resultant cells in adoptive cell therapies are also provided.


Find Patent Forward Citations

Loading…